HomeInsightsStock Comparison

Dr Reddys Laboratories Ltd vs Mono Pharmacare Ltd Stock Comparison

Dr Reddys Laboratories Ltd vs Mono Pharmacare Ltd Stock Comparison

Last Updated on: May 16, 2025

Key Highlights

  • The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1229 as of 16 May 10:22.
  • The P/E Ratio of Dr Reddys Laboratories Ltd changed from 25.6 on March 2020 to 18.4 on March 2024 . This represents a CAGR of -6.39% over 5 yearsThe P/E Ratio of Mono Pharmacare Ltd changed from 32 on March 2024 to 32 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 51797 crore on March 2020 to ₹ 102679 crore on March 2024 . This represents a CAGR of 14.67% over 5 yearsThe Market Cap of Mono Pharmacare Ltd changed from ₹ 77.92 crore on March 2024 to ₹ 77.92 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Dr Reddys Laboratories Ltd for the Mar '25 is ₹ 9056 crore as compare to the Dec '24 revenue of ₹ 8535 crore. This represent the growth of 6.1% The revenue of Mono Pharmacare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Dr Reddys Laboratories Ltd for the Mar '25 is ₹ 2525 crore as compare to the Dec '24 ebitda of ₹ 2427 crore. This represent the growth of 4.04% The ebitda of Mono Pharmacare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1405 crore to ₹ 1586 crore over 8 quarters. This represents a CAGR of 6.27% The net profit of Mono Pharmacare Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Dr Reddys Laboratories Ltd changed from 14.14 % on March 2020 to 15.37 % on March 2024 . This represents a CAGR of 1.68% over 5 yearsThe Dividend Payout of Mono Pharmacare Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

About Mono Pharmacare Ltd

  • Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
  • Mono Chemist' through Partnership Deed dated May 06, 1994.
  • The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad.
  • The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners.

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Lab jumps after Q4 PAT rises 22% YoY

Revenue from operations rose 20% year-on-year to Rs 8,506 crore, compared to Rs 7,083 cror...

Read more

12 May 2025 14:50

News

Dr Reddys Laboratories AGM scheduled

Dr Reddys Laboratories announced that the 41th Annual General Meeting(AGM) of the company ...

Read more

10 May 2025 10:17

News

Dr Reddys Lab Q4 PAT rises 22% YoY

Revenue from operations rose 20% year-on-year to Rs 8,506 crore, compared to Rs 7,083 cror...

Read more

10 May 2025 10:52

News

Board of Dr Reddys Laboratories recommends Final Dividend

Dr Reddys Laboratories announced that the Board of Directors of the Company at its meeting...

Read more

09 May 2025 17:01

News

Dr Reddys announces cessation of subsidiary in Louisiana

Dr. Reddy's Laboratories Inc., USA, a wholly owned subsidiary of the Company, has successf...

Read more

24 Mar 2025 13:48

News

Dr Reddys Laboratories to conduct board meeting

Dr Reddys Laboratories will hold a meeting of the Board of Directors of the Company on 9 M...

Read more

22 Mar 2025 11:01

Mono Pharmacare Ltd News Hub

News

Mono Pharmacare to conduct board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 28 May 202...

Read more

13 May 2025 16:38

News

Mono Pharmacare announces board meeting date

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 April 2...

Read more

05 Apr 2025 14:35

News

Mono Pharmacare to hold board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 2 April 20...

Read more

29 Mar 2025 09:47

News

Mono Pharmacare to convene board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 10 Februar...

Read more

03 Feb 2025 10:50

News

Mono Pharmacare announces board meeting date

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 January...

Read more

04 Jan 2025 10:27

News

Mono Pharmacare to convene board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 14 Novembe...

Read more

07 Nov 2024 15:32

SWOT Analysis Of Mono Pharmacare Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Mono Pharmacare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dr Reddys Laboratories Ltd and Mono Pharmacare Ltd

Which company has a larger market capitalization, Dr Reddys Laboratories Ltd or Mono Pharmacare Ltd?

Market cap of Dr Reddys Laboratories Ltd is 103,042 Cr while Market cap of Mono Pharmacare Ltd is 42 Cr

What are the key factors driving the stock performance of Dr Reddys Laboratories Ltd and Mono Pharmacare Ltd?

The stock performance of Dr Reddys Laboratories Ltd and Mono Pharmacare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Reddys Laboratories Ltd and Mono Pharmacare Ltd?

As of May 16, 2025, the Dr Reddys Laboratories Ltd stock price is INR ₹1234.85. On the other hand, Mono Pharmacare Ltd stock price is INR ₹24.0.

How do dividend payouts of Dr Reddys Laboratories Ltd and Mono Pharmacare Ltd compare?

To compare the dividend payouts of Dr Reddys Laboratories Ltd and Mono Pharmacare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions